Cyclo Therapeutics announced that the company received a Notice of Allowance from the United States Patent and Trademark Office, or USPTO, regarding Cyclo Therapeutics’ U.S. Patent Application No. 17/289,137 titled, “Methods for Treating Alzheimer’s Disease.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CYTH:
